क्यूआर कोड

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine

The changes in the severe acute respiratory syndrome coronavirus 2 and the tapering of immunity after vaccination have propelled the need for a booster dose vaccine. We aim to evaluate B and T cell immunogenicity and reactogenicity of mRNA-1273 COVID-19 vaccine (100 µg) as a third booster dose after...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Auchara Tangsathapornpong, Sira Nanthapisal, Kanassanan Pontan, Pornumpa Bunjoungmanee, Yamonbhorn Neamkul, Arthit Boonyarangkul, Supattra Wanpen, Waraphon Fukpho, Sumana Jitpokasem, Phuntila Tharabenjasin, Peera Jaru-Ampornpan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2023-02-01
श्रृंखला:Vaccines
विषय:
COVID-19 vaccine
CoronaVac
AZD1222
mRNA-1273
booster dose
anti-SARS-CoV-2 IgG
ऑनलाइन पहुंच:https://www.mdpi.com/2076-393X/11/3/553
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन